INSTITUT LILY
The computed 12-month bankruptcy probability of INSTITUT LILY is 1.7% (moderate). The 2025 annual accounts show equity of €30k and a net result of €6k. Equity is growing by ~24.3% per year across the filed fiscal years. Its solvency ranks better than 43% of 4350 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €30k |
| Net result | €6k |
| Staff (FTE) | 6.2 |
| Better than sector | 43% |
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 18.8% | 28.3% | |
| Net result | €6k | €3k | |
| Equity | €30k | €17k | |
| Gross operating margin | €273k | €28k | |
| Staff costs | €239k | €43k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €31k | €37k | €23k | €17k | €35k |
| Net profit | €6k | €17k | €-2k | €-6k | €11k |
| Cash flow | €14k | €29k | €20k | €15k | €31k |
| Staff costs | €239k | €202k | €170k | €163k | €102k |
| Income taxes | €2k | €6k | €498 | €191 | - |
| Dividends | €0 | €5k | - | - | - |
| Total assets | €161k | €85k | €77k | €93k | €114k |
| Equity | €30k | €24k | €12k | €14k | €20k |
| Debt | €131k | €60k | €65k | €80k | €94k |
| of which ≤ 1y | €88k | €60k | €65k | €71k | €71k |
| of which > 1y | €43k | - | €0 | €9k | €23k |
| Working capital | €-19k | €-16k | €-38k | €-38k | €-35k |
| Employees (FTE) | 6.2 | 5.9 | - | - | 4.8 |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 0.78 | 0.74 | 0.43 | 0.46 | 0.51 |
| Quick ratio | 0.75 | 0.70 | 0.39 | 0.43 | 0.48 |
| Working capital ratio | -11.7% | -18.4% | -48.5% | -40.6% | -30.6% |
| Solvency | 18.8% | 28.8% | 15.4% | 14.6% | 17.3% |
| Debt / equity | 4.31 | 2.48 | 5.48 | 5.86 | 4.78 |
| Long-term debt ratio | 1.42 | - | 0.00 | 0.66 | 1.17 |
| Interest coverage | 2.03 | 14.38 | 8.92 | 6.25 | 9.19 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 3.7% | 20.6% | -2.2% | -6.5% | 9.4% |
| ROE | 19.6% | 71.5% | -14.0% | -44.8% | 54.4% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (25 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €161k | €85k | €77k | €93k | €114k |
| Fixed assets | 21/28 | €92k | €40k | €49k | €61k | €78k |
| Intangible fixed assets | 21 | €16k | €20k | €24k | €28k | €32k |
| Tangible fixed assets | 22/27 | €61k | €5k | €10k | €17k | €30k |
| Financial fixed assets | 28 | €15k | €15k | €15k | €15k | €15k |
| Current assets | 29/58 | €69k | €45k | €28k | €33k | €36k |
| Stocks & contracts in progress | 3 | €3k | €2k | €3k | €2k | €2k |
| Amounts receivable within one year | 40/41 | €6k | €6k | €5k | €3k | €2k |
| Cash & bank | 54/58 | €56k | €33k | €19k | €26k | €31k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €161k | €85k | €77k | €93k | €114k |
| Equity | 10/15 | €30k | €24k | €12k | €14k | €20k |
| Contributions / capital | 10/11 | €13k | €13k | €13k | €13k | €13k |
| Accumulated profits (losses) | 14 | €17k | €11k | €-1k | €611 | €7k |
| Amounts payable | 17/49 | €131k | €60k | €65k | €80k | €94k |
| Amounts payable after one year | 17 | €43k | - | €0 | €9k | €23k |
| Amounts payable within one year | 42/48 | €88k | €60k | €65k | €71k | €71k |
| Trade debts payable within one year | 44 | €11k | €16k | €21k | €13k | €7k |
| Income statement | ||||||
| Gross operating margin | 9900 | €273k | €247k | €198k | €183k | €137k |
| Operating result | 9901 | €23k | €26k | €1k | €-3k | €14k |
| Financial income | 75 | €24 | €19 | €23 | €0 | €13 |
| Financial charges | 65 | €16k | €3k | €3k | €3k | €4k |
| Result before taxes | 9903 | €8k | €23k | €-1k | €-6k | €11k |
| Income taxes | 67/77 | €2k | €6k | €498 | €191 | - |
| Net result for the period | 9904 | €6k | €17k | €-2k | €-6k | €11k |
| Result to be appropriated | 9905 | €6k | €17k | €-2k | €-6k | €11k |
| NACE primary | Beauty care and other beauty treatments(96220) |
| Legal form | Private limited company(610) |
| Incorporation | 21-02-2020 |
| Status | Active |
| Postal code | 1348 |
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
| Legal nameFR | INSTITUT LILY |